AddLife Aktie

AddLife EPS

Indtjening pr. aktie (EPS) for AddLife (ALIF B.ST) pr. 9. aug. 2026 er 4,60 SEK. I foregående år var Indtjening pr. aktie (EPS) 2,07 SEK — en ændring på 122,22 % (højere).

EPS

4,60SEK

YoY

122,22%

Senest opdateret:

Indtjening pr. aktie (EPS) for AddLife er 2026 4,60 SEK. Indtjening pr. aktie (EPS) for AddLife var 2025 2,07 SEK. Det falder dermed med 122,22% højere sammenlignet med året før.
Access this data via the Eulerpool API

AddLife Aktieanalyse

Hvad laver AddLife? AddLife AB is a publicly listed company from Sweden that operates in the medical technology and healthcare industry. The company was founded in 2015 through the merger of several companies. AddLife AB is headquartered in Stockholm and currently employs over 2,000 employees in Sweden, Denmark, Finland, Norway, and Germany. The business model of AddLife AB is based on the acquisition and integration of leading technology companies in the healthcare industry. These companies are integrated into the AddLife Group and supported. Through collaboration within the group, synergies can be leveraged and competitiveness can be increased. AddLife offers its customers a wide range of products and services in various sectors. The company operates in the areas of diagnostics & life science, medical technology, and laboratory products. Diagnostics & life science includes products in the field of in vitro diagnostics, food analysis, nuclear medicine, and animal health. AddLife offers a wide range of products and services that are used in disease research and diagnostics. In the medical technology sector, AddLife AB offers products used by the medical technology industry, hospitals, and healthcare facilities. The product range includes surgical instruments, neurosurgery, orthopedics, and cardiology. AddLife is also involved in the project development of complete solutions for customers in this field. In the laboratory products sector, AddLife AB offers products and services for laboratories and research facilities. The product range includes laboratory equipment, laboratory consumables, and life science products. AddLife also offers services in the maintenance and validation of laboratory equipment. AddLife AB also has its own product brand, Labkotec, which manufactures products for fluid control and environmental and process condition monitoring. Labkotec operates internationally and offers products for various industries, such as the food and beverage industry, energy and environmental industry, steel industry, as well as the chemical and pharmaceutical industry. AddLife is known for its innovative products and solutions and works closely with customers to find individual solutions for their needs. The company sees itself as a provider of solutions and services for the medical industry and aims to improve the health and well-being of people through its products and services. AddLife er et af de mest populære virksomheder på Eulerpool.com.

Hyppigt stillede spørgsmål om AddLife aktie

Indtjening pr. aktie (EPS) for AddLife er 4,60 SEK i 2026.

Indtjening pr. aktie (EPS) for AddLife ændrede sig fra 2,07 SEK til 4,60 SEK, hvilket repræsenterer en ændring på 122,22 %. Værdien er højere end i foregående år.

På Eulerpool kan du finde den fuldstændige historiske udvikling af Indtjening pr. aktie (EPS) AddLife siden 2006 – med årlige værdier, diagrammer og detaljeret analyse.

Indtjening pr. aktie måler den del af virksomhedens fortjeneste, der er allokeret til hver udestående aktie, og er en nøglekenntal til vurdering af en virksomheds rentabilitet pr. aktie.

EPS = Nettoindtjening / Udestående aktier

Access this data via the Eulerpool API

Resultatopgørelse — AddLife

Alle nøgletal — AddLife